Qin T.

Qin T. is a senior scientist specializing in biomarkers at IO Biotech since April 2022. Prior experience includes a research scientist role at PPD, focusing on functional service partnerships to support GSK Vaccine Development, and a flow cytometry specialist position at MilliporeSigma, where Qin led GLP-compliant testing for regulatory submissions. Other notable roles encompass contributions to oncology therapeutics and diagnostics as a senior scientist at Precision For Medicine, support for IND filing and Phase 1 clinical trials at MacroGenics, and pre-clinical studies of therapeutic proteins at Human Genome Sciences. Earlier experiences include research at GenVec and the University of Minnesota, where Qin developed adenovirus vectors and investigated NK lineage cells. Qin holds a Master of Science in Clinical Laboratory Science/Immunology from the University of Minnesota.